T1	Participants 542 740	2437 patients with a history of HSL were randomized to self-initiate treatment with ME-609, 5% acyclovir in ME-609 vehicle, or ME-609 vehicle (placebo) at the earliest sign of a cold sore recurrence
T2	Participants 793 831	1443 patients experienced a recurrence
T3	Participants 933 1068	patients receiving ME-609, 42% did not develop an ulcerative lesion compared with 35% of patients receiving acyclovir in ME-609 vehicle
T4	Participants 1327 1359	50% in patients receiving ME-609
T5	Participants 1461 1513	patients with positive herpes simplex virus cultures
